|
Overcoming the Blood–Brain Barrier for Gene Therapy via Systemic Administration of GSH‐Responsive Silica Nanocapsules
|
journal
|
December 2022 |
|
Self-Assembled DNA Nanoclews for the Efficient Delivery of CRISPR-Cas9 for Genome Editing
|
journal
|
August 2015 |
|
Viral vector‐based gene therapies in the clinic
|
journal
|
October 2021 |
|
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
|
journal
|
April 2016 |
|
Rapid DNA unwinding accelerates genome editing by engineered CRISPR-Cas9
|
journal
|
June 2024 |
|
A Single Administration of CRISPR/Cas9 Lipid Nanoparticles Achieves Robust and Persistent In Vivo Genome Editing
|
journal
|
February 2018 |
|
Lipid nanoparticle-based ribonucleoprotein delivery for in vivo genome editing
|
journal
|
March 2023 |
|
Cas9 deactivation with photocleavable guide RNAs
|
journal
|
April 2021 |
|
Clinical progress in genome-editing technology and in vivo delivery techniques
|
journal
|
March 2023 |
|
AAV5 delivery of CRISPR-Cas9 supports effective genome editing in mouse lung airway
|
journal
|
January 2022 |
|
Chemistry of Lipid Nanoparticles for RNA Delivery
|
journal
|
December 2021 |
|
Lipid-Nanoparticle-Based Delivery of CRISPR/Cas9 Genome-Editing Components
|
journal
|
May 2022 |
|
CRISPR Spherical Nucleic Acids
|
journal
|
October 2022 |
|
Endosomal Escape and Delivery of CRISPR/Cas9 Genome Editing Machinery Enabled by Nanoscale Zeolitic Imidazolate Framework
|
journal
|
December 2017 |
|
Engineered CRISPR-Cas9 nucleases with altered PAM specificities
|
journal
|
June 2015 |
|
Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo
|
journal
|
October 2014 |
|
Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells
|
journal
|
June 2015 |
|
Efficient genome editing in the mouse brain by local delivery of engineered Cas9 ribonucleoprotein complexes
|
journal
|
February 2017 |
|
A thermostable Cas9 with increased lifetime in human plasma
|
journal
|
November 2017 |
|
Characterizing a thermostable Cas9 for bacterial genome editing and silencing
|
journal
|
November 2017 |
|
Systemic nanoparticle delivery of CRISPR-Cas9 ribonucleoproteins for effective tissue specific genome editing
|
journal
|
June 2020 |
|
AsCas12a ultra nuclease facilitates the rapid generation of therapeutic cell medicines
|
journal
|
June 2021 |
|
Lipid nanoparticles with PEG-variant surface modifications mediate genome editing in the mouse retina
|
journal
|
October 2023 |
|
Engineering self-deliverable ribonucleoproteins for genome editing in the brain
|
journal
|
February 2024 |
|
Nanoparticle delivery of Cas9 ribonucleoprotein and donor DNA in vivo induces homology-directed DNA repair
|
journal
|
October 2017 |
|
Nanoparticle delivery of CRISPR into the brain rescues a mouse model of fragile X syndrome from exaggerated repetitive behaviours
|
journal
|
June 2018 |
|
Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR–Cas gene editing
|
journal
|
April 2020 |
|
Acid-degradable lipid nanoparticles enhance the delivery of mRNA
|
journal
|
August 2024 |
|
CRISPR in cancer biology and therapy
|
journal
|
February 2022 |
|
Engineering precision nanoparticles for drug delivery
|
journal
|
December 2020 |
|
Base editing: precision chemistry on the genome and transcriptome of living cells
|
journal
|
October 2018 |
|
Engineered materials for in vivo delivery of genome-editing machinery
|
journal
|
October 2019 |
|
Lipid nanoparticles for mRNA delivery
|
journal
|
August 2021 |
|
The next generation of CRISPR–Cas technologies and applications
|
journal
|
May 2019 |
|
Search-and-replace genome editing without double-strand breaks or donor DNA
|
journal
|
October 2019 |
|
In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates
|
journal
|
May 2021 |
|
Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors
|
journal
|
June 2020 |
|
The delivery challenge: fulfilling the promise of therapeutic genome editing
|
journal
|
June 2020 |
|
In vivo adenine base editing of PCSK9 in macaques reduces LDL cholesterol levels
|
journal
|
May 2021 |
|
Combinatorial design of nanoparticles for pulmonary mRNA delivery and genome editing
|
journal
|
March 2023 |
|
Protein stability promotes evolvability
|
journal
|
March 2006 |
|
Efficient delivery of genome-editing proteins using bioreducible lipid nanoparticles
|
journal
|
February 2016 |
|
On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticles
|
journal
|
December 2021 |
|
Lung-selective mRNA delivery of synthetic lipid nanoparticles for the treatment of pulmonary lymphangioleiomyomatosis
|
journal
|
February 2022 |
|
Delivering CRISPR: a review of the challenges and approaches
|
journal
|
January 2018 |
|
Improved genome editing by an engineered CRISPR-Cas12a
|
journal
|
December 2022 |
|
Highly efficient gene knockout in mice and zebrafish with RNA-guided endonucleases
|
journal
|
November 2013 |
|
A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity
|
journal
|
June 2012 |
|
Multiplex Genome Engineering Using CRISPR/Cas Systems
|
journal
|
January 2013 |
|
CRISPR technology: A decade of genome editing is only the beginning
|
journal
|
January 2023 |
|
In vivo hematopoietic stem cell modification by mRNA delivery
|
journal
|
July 2023 |
|
In vivo editing of lung stem cells for durable gene correction in mice
|
journal
|
June 2024 |
|
In utero gene editing for monogenic lung disease
|
journal
|
April 2019 |
|
Genome editing via non-viral delivery platforms: current progress in personalized cancer therapy
|
journal
|
March 2022 |
|
Microfluidic-prepared DOTAP nanoparticles induce strong T-cell responses in mice
|
journal
|
January 2020 |
|
Gene Therapy Targeting PCSK9
|
journal
|
January 2022 |
|
Viral Delivery Systems for CRISPR
|
journal
|
January 2019 |
|
Data from: Lung and liver editing using lipid nanoparticle delivery of a stable CRISPR-Cas9 RNP
|
dataset
|
January 2023 |
|
Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR/Cas9 genome editing
|
journal
|
January 2021 |
|
Lipid nanoparticles for delivery of RNA therapeutics: Current status and the role of in vivo imaging
|
journal
|
January 2022 |